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ABSTRACT 
 
When deriving health based exposure limits in recent years, attention has been drawn to 
susceptible subpopulations, in particular to children. We investigate the differences in 
kinetics between children and adults during inhalation of styrene as a typical category 3 
volatile organic compound (VOC), i.e. a gas with a high rate of alveolar absorption (due to 
low reactivity and low water solubility). Internal exposure was simulated using a 
physiologically based kinetic model over a broad range of airborne concentrations (1 to 1000 
ppm) and for an exposure time of up to eight hours according to the scenario in the acute 
exposure guideline level (AEGL) program. Age-specific anatomical and physiological 
parameters and compound-specific data were derived from the literature. The calculated 
concentrations in arterial blood are higher in children than in adults, and are highest in the 
newborn. For an 8-hour exposure to low concentrations, the calculated arterial concentration 
in the newborn is higher by a factor of 2.3 than in the adult. This is mainly due to the 
relatively high ventilation rate and the immature metabolism. With increasing airborne 
concentration, the ratio of arterial concentrations (newborn/adult) increases to a maximum of 
3.8 at 130 ppm in ambient air, and declines with further increments of concentration to a 
value of 1.7. This is because the metabolism of the newborn becomes non-linear at lower 
concentrations than in adults. At high concentrations, metabolism is saturated in both age 
groups. For shorter exposures, the dose-dependency of the concentration ratios 
(newborn/adult) is less pronounced. This is the first article to show that the intraspecies 
uncertainty factor may vary with concentration and duration of exposure.  
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INTRODUCTION 
 
Risk assessment paradigms have been refined over the years, and recently, increasing 
attention has been paid to sensitive subpopulations, in particular children. Exposure patterns 
have been considered in various age groups (Cohen Hubal et al. 2000). In addition, several 
authors have described age-dependent kinetics, which show lower metabolic elimination in 
the very young (Dourson et al. 2002, Ginsberg et al. 2004, Hattis et al. 2003, Renwick et al. 
2000, Scheuplein et al. 2002). 
 
A specific exposure scenario, namely the accidental release of industrial chemicals leading 
to an airborne exposure of the general population, requires risk assessment which includes 
the consideration of sensitive subpopulations. In this context, recent history also urges 
considering possible terrorist attacks with chemical warfare agents. Special programs exist, 
e.g. the US-EPA acute exposure guideline levels (AEGL) program, in which a series of 
health based airborne concentrations are derived to inform the risk managers. Whereas 
other programs are aimed at setting ‘safe’ levels, which are by definition below the no 
adverse effect level, acute exposure guideline levels cover a broad range of concentrations, 
related to varying degrees of health impairment. In the standing operating procedures for the 
development of AEGLs (US-AEGL committee, 2001), three levels are defined (AEGL 1: 
discomfort, AEGL 2: irreversible or other serious, long-lasting adverse effects, AEGL 3: life-
threatening effects or death) and several exposure times are considered (10 min, 30 min, 1 
h, 4 h and 8 h).  
 
Exposure of the general population includes that of sensitive subgroups who develop 
stronger effects (local or systemic) compared to the ‘normal’ population at the same external 
concentration. In sensitive subjects, higher systemic response may be due to toxicokinetic 
factors or to toxicodynamic factors. Toxicokinetic factors, e.g. higher uptake due to higher 
ventilation rates or reduced elimination rates, result in higher internal exposure, whereas a 
  
stronger response at the same level of internal exposure is indicative for a change in 
sensitivity due to toxicodynamic factors.  
 
The aim of this article is to quantify differences in internal concentrations based on age-
specific physiological parameters of uptake and of kinetics during inhalation exposure. We 
compared the internal concentrations of children in different age groups with the 
concentration of the ‘reference man’. A physiologically based kinetic model was applied in 
which the body is described by several compartments representing organs (e.g. Ramsey and 
Andersen, 1984). It offers the opportunity to adapt the input parameters to the properties of 
the chemical (partitioning, metabolism) and to the age-dependent anatomical and 
physiological data. For adults, the predictions of such multi-compartment models were 
verified by measurements from exposure to industrial VOCs and from drugs used in 
anesthesia (e.g. Fiserova-Bergerova, 1983). Recently, this approach has been used to 
model age-dependent differences in toxicokinetics at low concentrations (Pelekis et al. 2001, 
Price et al. 2003, Sarangapani et al. 2003). We apply the approach in the context of AEGLs, 
where the relevant concentrations cover a broad range and where age-dependent 
differences in metabolic capacity also play a role.  
 
 
MODEL DESCRIPTION 
 
Model structure 
A physiologically based kinetic model was used which describes the body as simplified 
system with seven compartments representing adipose tissue, muscle/skin, skeleton, brain, 
kidney, liver (with metabolic capacity characterized by Km and Vmax), and the remainder as 
vessel rich organs (Figure 1). A comparable model structure is often used to simulate the 
kinetics of volatile organic compounds (e.g. Ramsey and Andersen, 1984).  
 
  
Mathematical description 
In the model, the rhythmic process of breathing is simplified as continuous air stream to the 
alveolar region of the lungs ( PQ , alveolar ventilation rate). During VOC exposure, the inhaled 
stream contains the substance at a certain concentration ( IC ) corresponding to the 
concentration in ambient air. It flows along the alveolar membrane where gas exchange 
takes place, and leaves the region with a changed concentration XC in exhaled air. On the 
other side of the membrane, venous blood with a flow corresponding to the cardiac output 
CQ  and a VOC concentration VC  enters the alveolar region and leaves it as arterial blood 
with a changed concentration AC . The mass balance of the VOC in the lungs is described in 
the following equation:  
 Amount In =⋅+⋅=⋅+⋅= ACXPVCIP CQCQCQCQ  Amount Out 
. The VOC diffusion is driven by the concentration gradient, and at the end of passing the 
alveolar region, the ratio of concentrations in arterial blood and in exhaled air has 
equilibrated to the blood:air partition coefficient XAB CCP /= . Thus, the arterial concentration 
can be expressed as 
 
BPC
VCIP
A PQQ
CQCQC
/+
⋅+⋅
=  (1) 
VOCs entering the various organ/tissue groups via arterial blood are assumed to be 
distributed rapidly throughout the tissue volume. Let TC  be the VOC concentration in tissue 
T , and TV  the volume of tissue, then the change in TT CV ⋅ , the amount of VOC in tissue T , 
is equal to the difference of the concentrations in blood flowing in ( AC ) and out ( VTC ) of the 
tissue, by the blood flow TQ  through the tissue, and in metabolizing tissue also by the rate of 
elimination TRAM . 
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Elimination is assumed to occur only in the liver and is modeled via Michaelis-Menten 
kinetics with maxV  being the maximum rate of elimination and mK  the concentration (in 
venous liver blood) at which max21 VV = . 
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To account for age-related metabolic activity, maxV  is scaled by liver size and by a 
metabolism factor for the newborn (MFnewb.) and the 1-year-old child (MF1 y) representing the 
age-related reduced amount of the enzyme involved in the metabolism of the particular 
chemical: 
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VOC concentration in venous blood leaving each tissue group T  is determined by a 
tissue:blood partition coefficient TP . 
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Before returning to the lungs, venous blood from all the tissue groups in the model is mixed. 
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In this model, the following assumptions are implicit: the gas has no local reactivity (category 
3, US-EPA 1994), no ‘wash in-wash out’ phenomenon (Johanson 1991) in the airways, 
absorption exclusively in the alveoli, rapid gas exchange between alveolar air and capillary 
blood following the concentration gradient, and rapid distribution in tissue (well-mixed 
compartments). Blood flow from intestinal organs to the liver through the portal vein is 
simplified as direct blood flow to the liver. For the calculations we assumed constant 
concentrations in ambient air, and that the alveolar ventilation rate does not change during 
exposure (e.g. due to the exposure itself or due to physical activity).  
 
  
Styrene as model compound 
Styrene has been selected for the model calculations, as a typical category 3 gas, with 
chemical-specific data available in the literature. Styrene partition coefficients were assumed 
to be age-independent. They were taken from Meulenberg and Vijverberg (2000) to be 55.6, 
2.50, 57.3, 1.82, and 1.02 for blood:air, liver:blood, fat:blood, brain:blood, and kidney:blood, 
respectively. For the muscle/skin compartment, the reported partition coefficient of 1.29 for 
muscle:blood was used. As for the remaining compartments (vessel rich group, skeleton) no 
values are given, the coefficient of the liver was used for these tissues as an approximation. 
Data sets for the activity of the main metabolizing enzyme (cytochrome P450 2E1, = CYP 
2E1) were taken from Csanady et al. (1994): Vmax = 0.002 mmol/h per g liver (corresponding 
to 375 mg/h in the adult with a liver weight of 1800 g) and Km = 0.01 mmol/L venous blood 
(1.04 mg/L). CYP 2E1 protein content in liver samples was reported to be about 14% of adult 
content in newborns (1 to 7 days old) and about 50% in one-year-old children (Vieira et 
al.1996). For children aged 5 years and above, the CYP2E1 content per gram hepatic tissue 
was assumed to equal that of adults.  
 
Model calculations and sensitivity analysis 
For the model calculations, duration of exposure was limited to 8 hours, the maximum 
exposure duration considered in the AEGL scenario. A concentration range between 1 and 
1000 ppm was investigated because this range would be representative for AEGL values 
(Voss, personal communication). The course of concentrations in arterial blood was 
simulated for adults and for the ages 0, 1, 5, 10 and 15 years. The aim of the study was to 
compare the toxicokinetics of styrene in children with that of the ‘reference man’ (middle-
aged healthy male adult). This is done by calculating the child to adult ratio of arterial 
concentrations for each age group. For all numerical computations, the Matlab software (The 
MathWorks, Natick, MA; Version 6.5.1) was used. 
 
To determine the factors with major influence on the ratios of arterial concentrations, a 
sensitivity analysis was performed by calculating the ratio after changing each of the 27 
  
anatomical, physiological, and chemical-specific parameters by adding 20%. The anatomy 
and physiology of the ‘reference man’ was not changed. Three concentration levels were 
analyzed (1 ppm, 130 ppm, and 1000 ppm) with two different exposure times (1 hour and 8 
hours). Note that the increase of blood flow to one compartment leads to a corresponding 
change in the cardiac output, and that the increase of the cardiac output leads to a 
corresponding change of blood flows to all organs and tissues.  
 
 
SELECTION OF AGE-DEPENDENT ANATOMICAL AND PHYSIOLOGICAL DATA  
 
To account for age-related differences, values of the anatomical and physiological 
parameters had to be determined for different age groups. The selection of tissue masses, 
alveolar ventilation rates, cardiac output and tissue blood flow rates would be straightforward, 
if data was available from simultaneous measurements of all the parameters in different age 
groups (healthy subjects) using the same methodological tools under resting conditions. 
However, in the absence of this information, different sources have been used to collate the 
relevant information. Where more than one set of data was found, the selection was made 
according to the following criteria: reliability of the method, healthy subjects, and resting 
conditions investigated. Studies in which a broad age range is covered were preferred over 
studies with only one age group. In this article, anatomical and physiological data of the 
middle-aged healthy male adult was taken to serve as the reference (‘reference man’). For 
the other ages, we chose the newborn as well as the 1-, 5-, 10- and 15-year-old child. For 
the latter, values for the male were taken if available. The selected data is compiled in Table 
1.  
 
Body and organ weights 
Data were taken from the recent ICRP report (2003). The mass of the vessel rich 
compartment was calculated as the sum of the masses of active bone marrow, adrenals, 
alimentary system, gall bladder wall, heart, pancreas, respiratory system (trachea, larynx, 
  
lung tissue), spleen, thymus, thyroid and tonsils. The mass of the skeleton given in the ICRP 
report was correspondingly reduced by the mass of active bone marrow. The remaining 
small organs (e.g. eyes and ureters) were felt to represent a negligible portion of the body 
mass. The mass of the blood is not considered in the model.  
 
Cardiac output 
Data for cardiac presented in the ICRP report (2003) lacks consistency with body weight and 
growth for very young children. Therefore, we used data of Alverson et al. (1987) obtained in 
31 healthy children from repetitive measurements by noninvasive pulsed Doppler ultrasound 
during their first year of life. Left ventricular cardiac output was reported to be 210 ± 44 
mL/kg⋅min shortly after birth and 182 ± 44 mL/kg⋅min at the age of 1 year, corresponding to 
44 L/h (newborn, 3.5 kg) and 109 L/h (1-year-old, 10.0 kg). The authors had demonstrated a 
high correlation (r=0.98) of their ultrasound technique with invasive measurements by heart 
catheterization in a population of similar age (Alverson et al. 1982). For children 5 years old 
and above, values for cardiac output were taken from ICRP (2003).  
 
Alveolar ventilation 
Alveolar ventilation is the proportion of the total pulmonary ventilation which reaches the 
alveoli (tidal volume minus physiological dead space, which is roughly one third of the tidal 
volume under resting conditions, independent of age: Kerr 1976; Polgar and Weng, 1979). 
There have been several studies for newborns using different measuring methods. The 
following results (mean values) were obtained under adequate conditions (gas volume at 
normal body temperature and ambient barometric pressure, saturated with water vapor). 
Data from Evans et al. 1977 (147 mL/kg⋅min, mean age 22 hours), Sandberg et al. 1984 (142 
mL/kg⋅min, age 26 hours), Nelson et al. 1962 (169 mL/kg⋅min, age between of 26 hours to 3 
days) and Lagneaux et al. 1988 (227 mL/kg⋅min, mean age 16 days) was assessed. We 
estimated an alveolar ventilation rate of 42 L/h (200 mL/kg⋅min) for newborns, which is 
between the value reported by Lagneaux et al. and the other three authors. We took into 
  
consideration increasing basal oxygen consumption (Hill and Rahimtulla 1965) within the first 
three days of life (the period in which the three studies with low values of alveolar ventilation 
was performed) and the 2.5-fold higher energy/oxygen expenditure in neonates as compared 
to adults, which directly corresponds to the ventilation rates (Layton 1993). 
 
Data from infants (n=21, age 0.5 to 8.5 months: Lees et al. 1967) was recalculated and 
extrapolated to the age of one year. The value of 128 mL/kg⋅min (77 L/h) seems relatively 
low, probably due to measurements during cardiac catheterization (sleeping conditions). 
Using the basal metabolic rate in 1-year-old children reported to be 2.8 times higher than in 
newborns (ICRP 2003; see Table 1), a ventilation rate of 118 L/h was calculated for the age 
of 1 year. Finally, the value of 109 L/h was chosen, which is equal to the cardiac output and 
consistent with the ventilation rates for the older children. Using data from children and 
adolescents (n=72, age 5 to 16 years: Kerr 1976) and the equation given (QP [L/min] = 0.034 
⋅ Height [cm] + 0.395), alveolar ventilation rates of 246 L/h, 305 L/h and 364 L/h were 
calculated for the 5-, 10- and 15-year-old children, respectively. These values correspond 
well to those of the cardiac output for the 10- and 15-year old child, but the value of 246 L/h 
for the 5-year-old one seems relatively high compared to the cardiac output (204 L/h) and to 
the metabolic rate from ICRP (2003). Therefore, a value of 210 L/h has been estimated 
based on the ventilation rate in the 1-year-old child and on the ratio of metabolic rates. For 
the typical male adult, an alveolar ventilation rate of 390 L/h was chosen, corresponding to 
the cardiac output and the increase of the basal metabolic rate from 15 years to adulthood.  
 
Blood flow to organs and tissues 
Blood flow rates as percentage of cardiac output are given in the ICRP report (ICRP 2003) 
for the resting middle-aged male adult, based on a compilation of published data by Williams 
and Leggett (1989) and Leggett and Williams (1995). These data were used to calculate 
blood flow rates (L/h) for liver (arterial and portal flow), brain, kidney, adipose tissue (fat), 
muscle/skin and skeleton (without active bone marrow). For the vessel rich organs, blood 
flow rates were reported for active bone marrow, adrenals, heart, pancreas, spleen and 
  
thyroid, but not for the remaining organs of this group (alimentary system, respiratory system 
including lungs, thymus and tonsils). We decided to allocate the difference between cardiac 
output (390 L/h) and the sum of the blood flows to organs/tissues (333 L/h) to the group of 
the vessel rich organs.  
 
Values for blood flow to the brain were taken from a study in children and young adults 
(n=42, age 2 days to 22 years: Chiron et al. 1992) using SPECT with 133Xe. These values are 
in accordance with those from Schöning and Hartig (1996) using sonography, and the value 
for the 19 years-old adult is in agreement with that of the ICRP report for the male adult. For 
the kidney, specific blood flows measured by Doppler duplex sonography were reported to 
be 410 ± 120 mL/min per 100 g kidney independent of age (n= 62, age 1 to 16 years: 
Grunert et al. 1990). The mean value matches well that of 398 mL/min per 100 g kidney 
calculated from the ICRP report for male adults. In newborns, renal blood flow was 
calculated as a fraction of cardiac output (16.1 ± 3.7 %, Visser et al. 1992), resulting in a 
mean value of 472 mL/min per 100 g kidney.  
 
For the remaining five compartments (liver, adipose tissue, muscle/skin, vessel rich group 
and skeleton), there are few or no reports on blood flows in children. The following approach 
was chosen to bridge the data gap. First, specific blood flow rates (perfusion per gram tissue) 
were calculated from data in the ICRP Report (2003) for the male adult. These values were 
multiplied by the organ/tissue masses of the specific age in children to result in (preliminary) 
age-specific blood flow rates, assuming the relative flows of these five compartments to be 
equal to those in adults. As expected, for all age groups the resulting sum of tissue flows 
(brain, kidney and five remaining compartments) is lower than the cardiac output, as specific 
blood flow values are usually higher in children than in adults. This reflects the higher energy 
expenditure due to growth and higher body surface/weight ratio. In order to adjust the sum of 
all organ blood flows to the total cardiac output, normalization factors were calculated for 
each age group (see Table 1), which were then used to scale up the preliminary blood flows 
  
of the five compartments (all except brain and kidney) so that the sum of all blood flows 
(including brain and kidney) equals the cardiac output.  
 
 
RESULTS 
 
Styrene concentrations in arterial blood 
The concentration of styrene in the arterial blood increased with duration of exposure and did 
not reach steady state within the 8-hour exposure period for all concentrations in the 
investigated range between 1 and 1000 ppm. As expected, arterial concentrations decrease 
after cessation of exposure. Figures 2a, 3a and 4a demonstrate the results for 1, 100 and 
1000 ppm, respectively. In the newborn, the arterial concentrations are distinctly higher than 
in all other age groups. The concentration-time profile of the 1-year-old child can also be 
distinguished from the other profiles at 1 and 100 ppm. With increasing age, the profile 
became increasingly similar to that of the adult, with only small differences for the 15-year-
old child.  
 
Ratios of arterial concentrations (child/adult) 
The ratios of the arterial concentrations are shown in Figure 2b, 3b, and 4b for styrene 
concentrations in ambient air of 1, 100 and 1000 ppm, respectively. They reveal dose- and 
duration-dependence: in the newborn, the ratio reaches a maximum value of 2.3 after an 
exposure duration of about 1 hour at 1 ppm in ambient air (Figure 2b). For the other age 
groups, the maximum ratios are 1.5, 1.35, 1.25, and 1.2 for the 1-, 5-, 10- and 15-year-old 
child, respectively, reached after about 30 minutes. At 100 ppm in ambient air, in the 
newborn, the ratio has reached a value of 3.8 after 8 hours (Figure 3b). At 1000 ppm, the 
pattern for all age groups is similar to that at 1 ppm, with maximum ratios reached after a 
short duration of exposure.  
 
  
In Figure 5, the ratio is shown to depend on the styrene concentration in ambient air (values 
for 8 hour exposure). The maximum ratio of 3.8 is calculated for the newborn exposed at 130 
ppm. With increasing age, the maximum ratios become lower and occur at higher 
concentrations in ambient air. In the 15-year-old child, the maximum ratio is about 1.3 at an 
exposure to 300 ppm.  
 
As the highest values were calculated for the newborn, further calculations were performed 
in this age group in order to describe the complex relationship between the concentration 
ratio (newborn/adult) influenced by the external styrene concentration in the ambient air and 
the duration of exposure. The results are presented in a three dimensional graph (Figure 6a, 
with additional plan view: Figure 6b; note the logarithmic scale). As can be seen, exposure 
duration up to 1 hour resulted in concentration ratios lower than 2.5 independent of the 
ambient air concentration. For longer duration of exposure, the ratios increase continuously 
with increasing concentrations in the ambient air, reaching a maximum value at about 130 
ppm. With higher concentrations, the concentration ratios become lower. The plan view 
provides the best description of the exposure conditions in terms of duration and 
concentration in ambient air. The worst conditions for the newborn can be seen in terms of 
the most pronounced difference to the adult (red area: ratios higher than 3.0).  
 
Sensitivity analysis of the concentration ratio (newborn/adult) 
As the child-to-adult ratio of the concentration time profiles turned out to depend both on 
exposure time and concentration in the ambient air, a local sensitivity analysis for the 
newborn was performed for three concentrations and for two s. In Table 2, those parameters 
are compiled whose 20 % increase changes the ratio (positively or negatively) by more than 
1 %. When considering anatomical and physiological parameters, only those of the newborn 
were changed. For any exposure duration and for all concentrations, the alveolar ventilation 
rate (QP) has the highest impact on the ratios, increasing them with increasing values. 
Regarding the blood flow rates, that of adipose tissue (QF) is an important factor leading to 
lower ratios, and the results for the increased cardiac output (QC) mainly reflect the 
  
corresponding increase of QF (and the increase of QL, see below). The third group of 
sensitive parameters determines metabolism: Vmax, Km, the liver:blood partition coefficient 
(PL), the metabolism factor for the newborn (MFnewb) and the newborn’s liver volume (VL) . 
The two last mentioned factors have equal influence on the newborn’s Vmax which is 
important for the exposure at 1 ppm, but not at 1000 ppm. Alteration of Vmax (in newborn and 
adult) lowers the ratio at 1 ppm and increases it at the higher concentrations of 130 and 1000 
ppm. Km is an influential factor for 1 ppm (higher ratios) and 130 ppm (lower ratios). The 
blood flow to the liver (QL) is a relevant parameter exclusively for the low concentration of 1 
ppm.  
 
 
DISCUSSION 
 
This is the first article showing that toxicokinetic differences between children and adults are 
not only age-dependent but also depend on the level of external exposure and the exposure 
time. A model approach was used to quantify the differences for styrene, a typical class 3 
VOC. In order to conform with the US-EPA AEGL scenario, exposure duration was chosen to 
be up to eight hours, and exposure levels cover a wide range of concentrations (between 1 
ppm and 1000 ppm). The ratio of arterial concentrations (child/adult) has been selected as 
an appropriate comparison of the concentration in the ‘typical’ child of a certain age to that in 
the ‘reference man’. As the acute (neuro)toxicity of styrene is supposed to be due to the 
parent compound (Pierce et al. 1998), metabolites were not considered. The model we used 
has seven compartments and is a modification of the Ramsey and Andersen model (1984) 
for styrene. The modifications have been made in order to represent age-related differences 
in relative organ weights and organ flow rates (for example, the brain represents nearly 11 % 
of the body weight in the newborn, but only 2 % in the adult). Johanson (1991) added a 
‘wash in-wash out’ process to the model which describes the pre-alveolar epithelial 
disposition of the chemical during inhalation leading to lower alveolar concentrations than in 
ambient air, and to re-diffusion during exhalation. This is applicable in particular to solvents 
  
with high water solubility. For styrene as a typical category 3 gas with lipophilic properties, it 
is generally accepted that this phenomenon plays a minor role.  
 
Age-related anatomical and physiological data are most important when modeling age-
specific differences in kinetics. From the process of selecting and estimating the data, 
uncertainty seems to be highest for the blood flow rates to organs/tissues. However, as the 
sensitivity analysis demonstrates, the influence of blood flow rates on the concentration 
ratios (newborn/adult) is irrelevant, with the notable exception of the blood flow to adipose 
tissue (QF) and the blood flow to the liver (QL) (Table 2). QF plays a relatively important role 
during distribution within the first hours of exposure (large storage capacity of adipose tissue 
in case of styrene). QL’s influence on the ratio is restricted to low concentrations in ambient 
air (1 ppm) where the metabolism of styrene is flow-limited.  
 
Of all physiological parameters, the alveolar ventilation rate is the main factor responsible for 
the age-dependent higher internal exposure of children during inhalation. This is more or less 
independent of the concentration in ambient air and the duration of exposure (Table 2). The 
second important factor is the immature metabolism after birth, though not at very high 
concentrations when metabolism is saturated in both children and adults (see below). This is 
underlined by an additional calculation: setting the alveolar ventilation rate of the newborn to 
18.7 L/h (instead of 42 L/h, = alveolar ventilation equal to that in the adult on a body weight 
basis), and the metabolism factor to 1.0 (mature metabolism), the calculated concentration 
ratios (newborn/adult) of Figure 6 would be between 0.45 and 0.8. These values lower than 
1.0 result from higher circulation rates (leading to faster distribution) and higher liver weight 
on a body weight basis in the newborn.  
 
The parameters Vmax, Km, PL, MFnewb, and VL characterizing the metabolism also play an 
important role in determining the level of internal exposure (Table 2). Values for Vmax and Km 
were taken from Csanady et al. (1994) who estimated them from measured blood 
concentrations in experimentally exposed human volunteers. Alternatively, blood 
  
measurements from rats can be ‘scaled up’, as done by Ramsey and Andersen (1984). 
Using this method, Vmax and Km are calculated to be 169 mg/h and 0.36 mg/L, respectively, 
for a 73-kg ‘reference man’ (instead of 375 mg/h and 1.04 mg/L, as given by Csanady et al. 
1994). Using these lower values, the maximum of the concentration ratio (newborn/adult) 
after an 8-hour exposure is 3.9 (instead of 3.8) which is not markedly different, but it occurs 
at a concentration of 60 ppm in ambient air (instead of 130 ppm).  
 
Generally, the phenomenon of a dose-dependent maximum of the concentration ratios child 
to adult (Figure 5, ‘crest’ in Figure 6a) results from saturation of metabolism. While at low 
concentrations the metabolism depends on hepatic blood flow, it becomes saturated with 
higher inhalation exposure. In children, the proportion of saturation is higher due to higher 
internal exposure, which again leads to higher concentrations. The phenomenon is marked in 
young children due to their immature metabolism. With inhalation of even higher 
concentrations, metabolism is capacity-limited in all age groups and in the adult, and plays a 
minor role for determining internal concentrations. As a consequence, the child/adult ratios 
diminish.  
 
In recent years, interest has grown in the susceptibility of children towards environmental 
chemicals. Lower metabolism rates in the very young have been reported by several authors 
(Cresteil 1998, Hattis et al. 2003). Pelekis et al. (2001) and, more recently, Price et al. (2003) 
and Sarangapani et al. (2003) have presented derivations of the adult to child kinetic 
uncertainty factors for inhalation exposure, based on physiological models. The ratios 
reported for styrene concentrations of 1 ppm by Sarangapani et al. (2003) in the 1-month-old 
(1.95) and the 1-year-old infant (1.49) match well with the results we obtained (2.61 for the 
newborn and 1.41 for the 1-year-old child). However, as they restricted their calculations to 
the low concentration and steady state conditions, they did not observe the ratio’s 
dependency on concentration and duration, which is important in case of acute exposure to 
high concentrations in ambient air.  
 
  
Conclusion 
Our model simulations revealed that the concentration ratios (child/adult) are the result of a 
complex interaction of different factors: 1. age-related differences in physiological and 
anatomical parameters, 2. the physicochemical properties of the chemical, 3. the duration of 
exposure, and 4. the concentration in ambient air. If specific partition coefficients and 
metabolic constants are known for a chemical, a physiologically based model can be used to 
quantify the expected kinetic differences for a specific exposure situation. In risk assessment, 
e.g. in deriving acute exposure guideline levels (AEGLs), the concentration ratios 
(child/adult) calculated can be used to establish intraspecies assessment factors to account 
for kinetic differences between children and adults. In cases where chemical-specific data is 
not available, the default factor of 3.2 is often applied to considertoxicokinetic differences 
within the human population (Dourson et al. 2002, Hattis et al. 2003). This factor has to be 
reconsidered: in some cases, a higher factor may be more appropriate to cover highly 
susceptible populations, such as the newborn.  
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Table 1  Anatomical and physiological data used for the simulation model. Data of children of 
different age and for the healthy, male adult (‘reference man’) under resting conditions (for 
sources: see text. Bold parameters: used directly for the model; other parameters are 
displayed as additional information for interpretation).  
 
Age  newborn 1 y 5 y 10 y male 15 y  male adult 
         
Body weight a (kg) 3.5 10.0 19.0 32.0 56.0  73.0 
Body height a (cm) 51 76 109 138 167  176 
Body surface Area a (m2)  0.24 0.48 0.78 1.12 1.62  1.90 
         
BMR a (kcal/h) 8.5 24.0 45.0 53.0 63.0  68.0 
BMR (kcal/kg⋅h) 2.43 2.40 2.37 1.66 1.13  0.93 
         
Alveolar ventilation QP(L/h) 42 109 210 305 364  390 
QP. per kg bw (L/kg⋅h) 12.0 10.9 11.1 9.5 6.5  5.3 
Cardiac Output (L/h) 44 109 204 300 366  390 
         
Organ weights a (g b)        
Blood  290 530 1500 2500 4800  5600 
Adipose tissue 930 3800 5500 8600 12000  18200 
Liver  130 330 570 830 1300  1800 
Brain  380 950 1310 1400 1420  1450 
Kidney  25 70 110 180 250  310 
Muscle, skin 975 2250 6170 11820 26000  32300 
Other Vessel rich organs  204 566 1141 1958 3071  3768 
Skeleton (without act. marrow) 320 1020 2090 3870 6870  9330 
         
Sum of organ weights (g)  3254 9516 18391 31158 55711  72758 
Rel. liver mass (g/kg) 37 33 30 26 23  25 
Rel. mass of adip.tiss.(g/kg) 266 380 289 269 214  249 
         
Metabolism factor  0.14 0.50 1 1 1  1 
         
Normalization factor blood flow 2.23 1.92 2.10 2.12 1.58  1.00 
         
Blood flow rates (L/h)         
Adipose tissue 1.7 6.1 9.7 15.3 16.0  19.5 
Brain  11.4 33.6 55.8 57.1 48.6  46.8 
Kidney  7.1 17.2 27.1 44.3 61.5  74.1 
Muscle, skin 5.0 9.7 26.7 49.9 83.0  85.8 
Vessel rich group  5.7 13.5 29.8 51.6 60.4  56.5 
Skeleton  0.5 1.3 2.9 5.4 7.1  7.8 
Liver  12.6 27.5 52.0 76.4 89.4  99.5 
Rel. hepatic blood flow (L/kg⋅h) 3.6 2.8 2.7 2.4 1.6  1.4 
 
a 
 from ICRP 2003 
b
 specific weight of 1.0 assumed for the model calculations 
 
  
Table 2  Sensitivity analysis of the ratio of arterial concentrations (newborn/adult) for three different concentrations of styrene in ambient air with a 
duration of 1 hour and 8 hours, respectively. A single change of +20% for each parameter was simulated (for the anatomical and physiological 
parameters, only those of the newborn were changed). For each concentration, those parameters with an impact on the concentration ratio higher 
than 1 % are listed in descending order, with the amount of relative change given in parentheses. The calculations were made for all 27 model 
parameters: Vmax (=Vmax adult in equation 2d) and the factor defining the enzyme immaturity in newborn (MFnewb), Km, 8 partition coefficients (PTissue), 7 
flow rates to organs/tissues (QTissue which correspondingly increase of QC), 7 organ/tissue volumes, QP and QC (all flow rates to organs/tissues 
increased by 20%). For abbreviations of organs/tissues see Figure 1. 
 
   duration of exposure: 1 hour       duration of exposure: 8 hours 
 1 ppm   130 ppma  1000 ppm    1 ppm   130 ppma  1000 ppm 
 QP (+15.1 %)  QP (+15.9 %)  QP (+14.8 %)    QP (+14.3 %)  QP (+13.6 %)  QP (+11.7 %) 
 QC (-6.2 %)  QC (-6.8 %)  QC (-6.9 %)    VL (-8.5 %)  QF (-9.6 %)  QF (-9.8 %) 
 VL (-5.7 %)  QF (-5.7 %)  QF (-5.7 %)    MFnewb (-8.4 %) QC (- 9.4%)  QC (-9.6 %) 
 MFnewb (-5.4 %) VMS (-3.8 %)  Vmax (+4.2 %)    QC (-6.4 %)  Km (-3.8 %)  Vmax (+5.1 %) 
 QF (-4.3 %)  VL (-3.6 %)  VMS (-3.9 %)    Vmax (-5.5 %)  PB (+3.7 %)  PMS (+1.7) 
 PL (-3.5 %)  MFnewb (-2.6 %) VBr (-2.6 %)    PL (-5.3 %)  VL (-3.5 %)  PB (+1.7 %) 
 Vmax (-3.3 %)  VBr (-2.4 %)  PBr (+2.0 %)    Km (+4.4 %)  MFnewb (-3.4 %) VF (-1.6 %) 
 VMS (-2.7 %)  PBr (-2.2 %)  VVR (-1.9 %)    QF (-4.3 %)  PL (+3.3 %)    
 Km (+2.6 %)  Km (-2.0 %)  VL (-1.6 %)    QL (-2.1 %)  Vmax (+2.6 %)    
 QL (-1.5 %)  VVR (-1.8 %)       PB (+1.4 %)  VF (-1.6 %)    
 VBr (-1.4 %)  PB (+1.3 %)       VF (-1.0 %)  PF (-1.2 %)    
 PBr (+1.2 %)                  
 VVR (-1.1 %)                  
 
a
 130 ppm is the maximum of the ratios of arterial concentrations (newborn/adult) after 8-hour exposure (see Figures 5 and 6).  
  
Figure legends 
 
 
 
Figure 1 
Diagram of the kinetic simulation model, including parameter abbreviations used.  
 
 
Figure 2, 3 and 4 
Model calculations for the inhalation exposure to styrene, with concentrations in ambient air 
of 1 ppm (Figure 2), 100 ppm (Figure 3) and 1000 ppm (Figure 4).  
a: Concentration-time profile in arterial blood during styrene exposure for 8 hours and the 
following 8 hours in children (newborn, 1-, 5-, 10- and 15-year-old) and the adult.  
b: corresponding ratios of arterial concentrations (child/adult) during the 8-hour exposure.  
 
 
Figure 5 
Ratios of arterial concentrations (child/adult) after a styrene exposure duration of 8 hours, 
depending on the concentration in ambient air, in children of different ages (newborn, 1-, 5-, 
10- and 15-year-old).  
 
 
Figure 6 
Ratios of arterial concentrations (newborn/adult), depending in the duration of exposure (0 to 
8 hours) and the styrene concentration in ambient air (note the logarithmic scale). Figure 6a 
shows the results as three dimensional graph, Figure 6b shows the plan view.  
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